NCT02839278
Completed
Not Applicable
Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Blood sample
- Conditions
- Inflammation
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Expression of costimulatory molecules CD86, CD80, CD40 and class II (HLA-DR) on monocytes
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The aim of the study is to investigate in vitro the impact of a novel anti-inflammatory treatment on costimulatory molecules expressed on monocytes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Immune-mediated inflammatory disease (non-ST segment elevation myocardial infarction, Rheumatoid arthritis, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Crohn's disease, Ulcerative colitis, Cystic fibrosis, Psoriasis, Multiple sclerosis or major depressive episode)
- •Patient able to understand the reason of the study
- •Patient not opposed to the conservation of biological samples for scientific research
Exclusion Criteria
- •Pregnant woman
- •Subject without health insurance
Arms & Interventions
Immune-mediated inflammatory disease
Patients with an immune-mediated inflammatory disease. A blood sample is achieved at T0 (no follow-up).
Intervention: Blood sample
Outcomes
Primary Outcomes
Expression of costimulatory molecules CD86, CD80, CD40 and class II (HLA-DR) on monocytes
Time Frame: 24 months
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in PsoriasisPsoriasis VulgarisNCT06042647Dermatology Consulting Services, PLLC10
Completed
Not Applicable
In Vitro And Ex Vivo Anti-Inflammatory Activities Of Salmon Polar LipidsCardiovascular DiseasesNCT03603769University of Limerick6
Completed
Not Applicable
Pilot study to investigate the anti-inflammatory effects of caffeine in subjects with chronic obstructive pulmonary disease (COPD)chronic inflammationchronic obstructive pulmonary disease (COPD)10038716NL-OMON31548Technologiestichting STW (NWO)12
Completed
Not Applicable
Clinical study to evaluate anti-inflammatory effects of intravenous azithromycin add-on therapy for the treatment of bacterial pneumonia.PneumoniaJPRN-UMIN000008010Yokohama City University Medical Center80
Recruiting
Phase 3
A study on therapeutic and anti-inflammatory effects of probiotic in asthmatic patients referred to kowsar semnan hospitalAsthmatic.Mild intermittent asthma with status asthmaticusJ45.22IRCT20151228025732N54Semnan University of Medical Sciences60